Cardiff Oncology: What Storms Can We Expect In 2026? The Case For Measured Enthusiasm [Seeking Alpha]
Cardiff Oncology (NASDAQ:CRDF) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $12.00 price target on the stock.
3 Penny Stocks With At Least $100M Market Cap [Yahoo! Finance]
Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025
Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference